Glaxo Wellcome UK Ltd T/A GSK has informed us of an issue related to error in the decommissioning of a specific batch of Beconase Aqueous Nasal Spray. Upon decommissioning at the pharmacy and when scanning the serialised 2D code, the status of packs may report as ‘DESTROYED.’ Although there is no risk to product quality, any remaining stock should be quarantined and returned.

Full details of the drug alert are included in the attached PDF file. Please forward to listed recipients. This information is also published on the MHRA website https://www.gov.uk/drug-device-alerts.

Falsified Medicines Directive (FMD) 2011/62/EU introduced new requirements to enhance the security of the European supply chain. Where the MHRA has identified risks to the security of the supply chain, FMD Alerts will be issued. For further information about FMD and safety features, please see this link on GOV.UK.